Member Info for zebbo

The downside of Nas listing

Never take holdings as a proxy to buy or sell. By the time you hear of any buys/sells the action has generally closed. There are so many factors as to why they are sold and bought.
Chase these types of updates at your peril, rear view indicator if ever there was one

Have not read all the posts related to the overhang. Will be cleared by midweek is what I have heard

For investors its provided a longer term opportunity....fillyerboots

Looks like the market is awaiting an update....

Buying , now oversold, will bounce

Thats what the market is telling us at the mo

and got lambasted for putting forwards a balanced view...

So much paranoia mixed with a good slug of naive traders.

Dont get blindsided, some cannot look at this investment in a balanced manner

Or have already forward sold

The more IIs spread there risk the better, its as simple as that. They will get winners and loosers..

Dont forget these IIs are using "your" PI money usually through ETF etc, not theirs when making a purchase

struggling to see what the value of Imutex is, can anyone shed any light on this? Looks to be a non listed and part of Seek Group. However I have seen some figs posted in the past but cannot remember the source or value attributed to Imutex

Where does the ORPH fit - The antibody tests, which utilise the Quotient MosaiQ™ system and MosaiQ COVID-19 Antibody Microarray, offer best in class COVID-19 antibody testing performance

We would have 62% of 100% if it was a straight cut. BUT PrEP have licensed from J&J and we dont know the license terms.

So terms of the license are key to knowing what we have exactly. Eg If PrEP and J&J are 50/50, we have 62% of 50%

Funny when I posted the EO Aug timeline "with risk" (in non ramping mode) I got cynical remarks as to my motive. Even as a holder...
Ophidian posted the same timeline and most agree, with a pat on the back.
Strange old world....lol

*hear, predictive

I do hold
Whats the point of a BB if you cannot speak freely!!
If all you want to here is AVCT will concour the world, we will all be millionaires, £20 per share etc etc
Cheap as chips at £1.50, yes, but since then more and more information has come to light with COV and AVCT etc etc. Things change. Wake up man

Forgot to add how will this all fit with track and trace

If we get a prototype EO June. Then test for 4wks est (EO July), then production, first products (EO Aug) again an estimate
Current orders or forward expressions of interest = nil
Other than production, the other sizable risk is that other (non AVCT) testing processes and procedures continue to be bedded down. If these are working ok they will not want to disrupt what is already working. Not forgetting that they will have another 2-3 month to perfect or iron out any current testing wrinkles.
Feels like we cannot have a single slip up and if anything need to accelerate our product and sales plan
Currently holding, just putting down whats on my mind